Tofacitinib, also known as Tasocitinib, is a novel inhibitor of Janus kinase 3 (JAK3), a critical cytoplasmic tyrosine kinase in the signaling pathways of multiple cytokines. Research suggests Tofacitinib acts as an immunosuppressant, preventing organ transplant rejection, and that it has potential to alleviate symptoms of autoimmune diseases, such as rheumatoid arthritis and psoriasis. _x000D_
Cerere de ofertă
Indisponibil
Număr Catalog 421-27037CategorieAfaceri și industrie > Știință și laboratorFurnizorBPS BioscienceGentaurDimensiune25 mgTipsingle